Syndromic microphthalmia

Last updated
Syndromic microphthalmia
Symptoms Abnormally small eyeball(s)
Usual onsetBirth [1]
DurationLifelong [1]
CausesGenetic or environmental factors [1]
Frequency1 in 10,000 individuals [1]

Syndromic microphthalmia is a class of rare congenital anomalies characterized by microphthalmia along with other non-ocular malformations. [2] Syndromic microphthalmia accounts for 60 to 80% of all cases of microphthalmia. [2] Syndromic microphthalmias are caused by mutations in genes related to embryonic craniofacial development, and they are typically classified based on their genetic cause.

Contents

Classification

If microphthalmia is present, genetic testing can be done to inform a specific diagnosis of a named syndrome. Twenty to forty percent of anophthalmia and microphthalmia patients are diagnosed with a recognized syndrome. [2] There are 14 numbered syndromic microphthalmies (MCOPS) primarily defined by their ocular manifestations:

MCOPS classification
TypeCausative gene/locusInheritance [lower-alpha 1] Synonyms
MCOPS1 NAA10 [3] XL Lenz microphthalmia syndrome
MCOPS2 BCOR [4] XLR
XLD oculofaciocardiodental syndrome
MCOPS3 SOX2 [2] ADSOX2 anophthalmia syndrome, anophthalmia/microphthalmia-esophageal atresia (AEG) syndrome
MCOPS4 Xq27-q28 [2] XLRmicrophthalmia-ankyloblepharon-intellectual disability syndrome
MCOPS5 OTX2 [2] ADOTX2-related eye disorders
MCOPS6 BMP4 [5] ADBakrania-Ragge syndrome, microphthalmia with brain and digit anomalies
MCOPS7 HCCS, COX7B, NDUFB11 [2] [6] XLD MIDAS syndrome, microphthalmia with linear skin defects (MLS) syndrome
MCOPS8 SNX3 [7] ADmicrocephaly-microphthalmia ectrodactyly of lower limbs and prognathism (MMEP) syndrome, Viljoen–Smart syndrome
MCOPS9 STRA6 [8] ARanophthalmia/microphthalmia and pulmonary hypoplasia, Spear syndrome, Matthew–Wood syndrome
MCOPS10unknown [2] microphthalmia and brain atrophy (MOBA) syndrome
MCOPS11 VAX1 [2] ARN/A
MCOPS12 RARB [2] AD, ARmicrophthalmia with or without pulmonary hypoplasia, diaphragmatic hernia, and/or cardiac defects
MCOPS13 HMGB3 [2] XLcolobomatous microphthalmia with microcephaly, short stature, and psychomotor retardation, Maine microphthalmos
MCOPS14 MAB21L2 [2] AD, ARcolobomatous microphthalmia-rhizomelic dysplasia syndrome, microphthalmia-coloboma-rhizomelic skeletal dysplasia

In addition to MCOPS1–14, there are many genetic syndromes of which microphthalmia is a key feature: [2]

Syndromes causing microphthalmia
Causative gene/locusInheritance [lower-alpha 1] Name/synonyms
unknownXLD Aicardi syndrome (AIC), agenesis of corpus callosum with chorioretinal abnormality
KIAA1109 ARAlkuraya–Kucinskas syndrome (ALKKCUS)
MAF ADAymé–Gripp syndrome (AYGRP)
ACTB AD Fryns-Aftimos syndrome, Baraitser–Winter syndrome 1 (BRWS1)
ACTG1 ADBaraitser–Winter syndrome 2 (BRWS2)
unknown Biemond syndrome
FOXL2 AD Blepharophimosis, ptosis, epicanthus inversus syndrome (BPES)
SMCHD1 ADBosma arhinia microphthalmia syndrome (BAMS)
TFAP2A AD Branchio-oculo-facial syndrome (BOFS), hemangiomatous branchial clefts-lip pseudocleft syndrome
ERCC6 AR Cockayne syndrome type B (CSB), cerebro-oculo-facio-skeletal syndrome 1 (COFS1)
CHD7 AD CHARGE syndrome
HDAC6 XLDChondrodysplasia with platyspondyly, distinctive brachydactyly, hydrocephaly, and microphthalmia
unknownColobomatous microphthalmia-obesity-hypogenitalism-intellectual disability syndrome
YAP1 ADColoboma, ocular, with or without hearing impairment, cleft lip/palate, and/or intellectual disability (COB1)
FAT1 ARColobomatous microphthalmia, ptosis, nephropathy, and syndactyly
MITF AD Waardenburg syndrome type 2
ARCOMMAD syndrome
SRD5A3 AR Congenital disorder of glycosylation type 1q (CDG1q)
SMO unknown Curry–Jones syndrome (CJS)
SALL4 AR Duane-radial ray syndrome, Okihiro syndrome
FANCA, FANCD2, FANCE, FANCI, FANCL AR Fanconi anemia complementation groups A, D2, E, I, L
PORCN XLD Focal dermal hypoplasia, Goltz-Gorlin syndrome
FRAS1 AR Fraser syndrome 1
FREM2 ARFraser syndrome 2
GRIP1 ARFraser syndrome 3
ALX3 AR Frontonasal dysplasia 1 (FND1)
ALX1 AR Frontonasal dysplasia 3 (FND3)
unknownAR Fryns syndrome
unknown GOMBO syndrome (growth retardation, ocular abnormalities, microcephaly, brachydactyly, and oligophrenia)
SLC25A24 ADGorlin–Chaudhry–Moss syndrome
FAM111A ADGracile bone dysplasia (GCLEB), Kenny-Caffey syndrome
unknown Hallermann–Streiff syndrome
SMG9 ARHeart and brain malformation syndrome (HBMS)
14q32 AD Hemifacial microsomia
SIX3 , SHH , PTCH1 , GLI2 AD Holoprosencephaly types 1, 2, 3, 7, 9
IKBKG XLD Incontinentia pigmenti
PDE6D AR Joubert syndrome 22
unknownAR Kapur–Toriello syndrome
KMT2D AD Kabuki syndrome
KDM6A XLD
GDF6 AD Klippel–Feil syndrome types 1, 3
GDF3 XLD
unknownXLDMacrosomia with lethal microphthalmia
FREM1 ARManitoba oculotrichoanal syndrome (MOTA)
MKS1 , TMEM216 , TMEM67 , CEP290 , RPGRIP1L AR Meckel–Gruber syndrome types 1-5
unknownlikely AD MOMO syndrome
ZEB2 AR Mowat–Wilson syndrome
POMT1 AD Muscle–eye–brain disease type A 1-11
POMT2 , POMGNT1 , FKTN , FKRP , CRPPA , POMGNT2 , DAG1 , RXYLT1 , B3GALNT2 AR
NHS XLD Nance–Horan syndrome
RERE ADNeurodevelopment disorder with anomalies of the brain, eye, and/or heart (NEDBEH)
NPD XLR Norrie disease
HMX1 AR Oculoauricular syndrome
GJA1 AD, AR Oculodentodigital dysplasia (ODD)
CPLANE1 AR Orofaciodigital syndrome type VI
LRP5 AR Osteoporosis-pseudoglioma syndrome
PAX2 AD Papillorenal syndrome
ATOH7 AR Persistent fetal vasculature (PFV)/persistent hyperplastic primary vitreous (PHPV)
RIPK4 AR Popliteal pterygium syndrome (PPS)
PQBP1 XLR Renpenning's syndrome
RBP4 ARRetinal dystrophy, iris coloboma and comedogenic acne syndrome (RDCCAS)
DLX1 , DLX2 AD Split-hand/foot malformation type V
C12orf57 ARTemtamy syndrome
WNT3 AR Tetra-amelia syndrome
SALL1 AD Townes–Brocks syndrome
PUF60 ADVerheij syndrome
RAB3GAP1, RAB3GAP2, RAB18, TBC1D20 AR Warburg Micro syndrome 1-4

Notes

  1. 1 2 AD: autosomal dominant; AR: autosomal recessive; XL: X-linked; XLD: X-linked dominant; XLR: X-linked recessive

Related Research Articles

<span class="mw-page-title-main">Coloboma</span> Hole in one of the structures of the eye

A coloboma is a hole in one of the structures of the eye, such as the iris, retina, choroid, or optic disc. The hole is present from birth and can be caused when a gap called the choroid fissure, which is present during early stages of prenatal development, fails to close up completely before a child is born. Ocular coloboma is relatively uncommon, affecting less than one in every 10,000 births.

Microphthalmia, also referred as microphthalmos, is a developmental disorder of the eye in which one or both eyes are abnormally small and have anatomic malformations. Microphthalmia is a distinct condition from anophthalmia and nanophthalmia. Although sometimes referred to as 'simple microphthalmia', nanophthalmia is a condition in which the size of the eye is small but no anatomical alterations are present.

<span class="mw-page-title-main">CHARGE syndrome</span> Medical condition

CHARGE syndrome is a rare syndrome caused by a genetic disorder. First described in 1979, the acronym "CHARGE" came into use for newborn children with the congenital features of coloboma of the eye, heart defects, atresia of the nasal choanae, restricted growth and/or development, genital and/or urinary abnormalities, and ear abnormalities and deafness. These features are no longer used in making a diagnosis of CHARGE syndrome, but the name remains. About two thirds of cases are due to a CHD7 mutation. CHARGE syndrome occurs only in 0.1–1.2 per 10,000 live births; as of 2009, it was the leading cause of congenital deafblindness in the US.

<span class="mw-page-title-main">Intraflagellar transport</span> Cellular process

Intraflagellar transport (IFT) is a bidirectional motility along axoneme microtubules that is essential for the formation (ciliogenesis) and maintenance of most eukaryotic cilia and flagella. It is thought to be required to build all cilia that assemble within a membrane projection from the cell surface. Plasmodium falciparum cilia and the sperm flagella of Drosophila are examples of cilia that assemble in the cytoplasm and do not require IFT. The process of IFT involves movement of large protein complexes called IFT particles or trains from the cell body to the ciliary tip and followed by their return to the cell body. The outward or anterograde movement is powered by kinesin-2 while the inward or retrograde movement is powered by cytoplasmic dynein 2/1b. The IFT particles are composed of about 20 proteins organized in two subcomplexes called complex A and B.

<span class="mw-page-title-main">Walker–Warburg syndrome</span> Medical condition

Walker–Warburg syndrome (WWS), also called Warburg syndrome, Chemke syndrome, HARD syndrome, Pagon syndrome, cerebroocular dysgenesis (COD) or cerebroocular dysplasia-muscular dystrophy syndrome (COD-MD), is a rare form of autosomal recessive congenital muscular dystrophy. It is associated with brain and eye abnormalities. This condition has a worldwide distribution. Walker-Warburg syndrome is estimated to affect 1 in 60,500 newborns worldwide.

<span class="mw-page-title-main">Cohen syndrome</span> Medical condition

Cohen syndrome is a very rare autosomal recessive genetic disorder with varied expression, characterised by obesity, intellectual disability, distinct craniofacial abnormalities and potential ocular dysfunction.

<span class="mw-page-title-main">Anophthalmia</span> Medical condition

Anophthalmia is the medical term for the absence of one or both eyes. Both the globe and the ocular tissue are missing from the orbit. The absence of the eye will cause a small bony orbit, a constricted mucosal socket, short eyelids, reduced palpebral fissure and malar prominence. Genetic mutations, chromosomal abnormalities, and prenatal environment can all cause anophthalmia. Anophthalmia is an extremely rare disease and is mostly rooted in genetic abnormalities. It can also be associated with other syndromes.

Vitamin A receptor, Stimulated by retinoic acid 6 or STRA6 protein was originally discovered as a transmembrane cell-surface receptor for retinol-binding protein. STRA6 is unique as it functions both as a membrane transporter and a cell surface receptor, particularly as a cytokine receptor. In fact, STRA6 may be the first of a whole new class of proteins that might be known as "cytokine signaling transporters." STRA6 is primarily known as the receptor for retinol binding protein and for its relevance in the transport of retinol to specific sites such as the eye. It does this through the removal of retinol (ROH) from the holo-Retinol Binding Protein (RBP) and transports it into the cell to be metabolized into retinoids and/or kept as a retinylester. As a receptor, after holo-RBP is bound, STRA6 activates the JAK/STAT pathway, resulting in the activation of transcription factor, STAT5. These two functions—retinol transporter and cytokine receptor—while using different pathways, are processes that depend on each other.

<span class="mw-page-title-main">USH2A</span> Protein-coding gene in the species Homo sapiens

Usherin is a protein that in humans is encoded by the USH2A gene.

<span class="mw-page-title-main">GPR143</span> Protein-coding gene in the species Homo sapiens

G-protein coupled receptor 143, also known as Ocular albinism type 1 (OA1) in humans, is a conserved integral membrane protein with seven transmembrane domains and similarities with G protein-coupled receptors (GPCRs) that is expressed in the eye and epidermal melanocytes. This protein encoded by the GPR143 gene, whose variants can lead to Ocular albinism type 1.

<span class="mw-page-title-main">CHRNE</span> Protein-coding gene

Acetylcholine receptor subunit epsilon is a protein that in humans is encoded by the CHRNE gene.

<span class="mw-page-title-main">HCCS (gene)</span> Protein-coding gene in humans

Cytochrome c-type heme lyase is an enzyme that in humans is encoded by the HCCS gene on chromosome X.

<span class="mw-page-title-main">VSX2</span> Protein-coding gene in the species Homo sapiens

Visual system homeobox 2 is a protein that in humans is encoded by the VSX2 gene.

<span class="mw-page-title-main">Hennekam syndrome</span> Medical condition

Hennekam syndrome also known as intestinal lymphagiectasia–lymphedema–mental retardation syndrome, is an autosomal recessive disorder consisting of intestinal lymphangiectasia, facial anomalies, peripheral lymphedema, and mild to moderate levels of growth and intellectual disability.

Microphthalmia–dermal aplasia–sclerocornea syndrome is a condition characterized by linear skin lesions. MLS is a rare X-linked dominant male-lethal disease characterized by unilateral or bilateral microphthalmia and linear skin defects in affected females, and in utero lethality for affected males. It can be associated with HCCS, mutations in it cause microphthalmia with Linear Skin Defects Syndrome.

Perlman syndrome (PS), also known as nephroblastomatosis-fetal ascites-macrosomia-Wilms tumor syndrome, is a rare overgrowth syndrome caused by autosomal recessive mutations in the DIS3L2 gene. PS is characterized by macrocephaly, neonatal macrosomia, nephromegaly, renal dysplasia, dysmorphic facial features, and increased risk for Wilms' tumor. The syndrome is associated with high neonatal mortality.

<span class="mw-page-title-main">FOXE3</span> Protein-coding gene in the species Homo sapiens

Forkhead box protein E3 (FOXE3) also known as forkhead-related transcription factor 8 (FREAC-8) is a protein that in humans is encoded by the FOXE3 gene located on the short arm of chromosome 1.

Impute.me. was an open-source non-profit web application that allowed members of the public to use their data from direct-to-consumer (DTC) genetic tests to calculate polygenic risk scores (PRS) for complex diseases and cognitive and personality traits. In July 2022, Lasse Folkerson, initiator and operator of impute.me, took the website offline.

<span class="mw-page-title-main">Waardenburg anophthalmia syndrome</span> Medical condition

Waardenburg anophthalmia syndrome is a rare autosomal recessive genetic disorder which is characterized by either microphthalmia or anophthalmia, osseous synostosis, ectrodactylism, polydactylism, and syndactylism. So far, 29 cases from families in Brazil, Italy, Turkey, and Lebanon have been reported worldwide. This condition is caused by homozygous mutations in the SMOC1 gene, in chromosome 14.

Curry–Jones syndrome is a rare genetic disorder characterized by congenital brain, osseous, cutaneous, ocular, and intestinal anomalies.

References

  1. 1 2 3 4 "Microphthalmia". MedlinePlus. US National Library of Medicine. Retrieved 2021-11-04.
  2. 1 2 3 4 5 6 7 8 9 10 11 12 13 Eintracht J, Corton M, FitzPatrick D, Moosajee M (2020). "CUGC for syndromic microphthalmia including next-generation sequencing-based approaches". Eur J Hum Genet. 28 (5): 679–690. doi:10.1038/s41431-019-0565-4. PMC   7171178 . PMID   31896778.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  3. George A, Cogliati T, Brooks BP (2020). "Genetics of syndromic ocular coloboma: CHARGE and COACH syndromes". Exp Eye Res. 193: 107940. doi:10.1016/j.exer.2020.107940. PMC   7310839 . PMID   32032630.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  4. Ng D, Thakker N, Corcoran CM, Donnai D, Perveen R, Schneider A; et al. (2004). "Oculofaciocardiodental and Lenz microphthalmia syndromes result from distinct classes of mutations in BCOR". Nat Genet. 36 (4): 411–6. doi: 10.1038/ng1321 . PMID   15004558. S2CID   23628891.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  5. Blackburn PR, Zepeda-Mendoza CJ, Kruisselbrink TM, Schimmenti LA, García-Miñaur S, Palomares M; et al. (2019). "Variable expressivity of syndromic BMP4-related eye, brain, and digital anomalies: A review of the literature and description of three new cases". Eur J Hum Genet. 27 (9): 1379–1388. doi:10.1038/s41431-019-0423-4. PMC   6777538 . PMID   31053785.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  6. van Rahden VA, Fernandez-Vizarra E, Alawi M, Brand K, Fellmann F, Horn D; et al. (2015). "Mutations in NDUFB11, encoding a complex I component of the mitochondrial respiratory chain, cause microphthalmia with linear skin defects syndrome". Am J Hum Genet. 96 (4): 640–50. doi:10.1016/j.ajhg.2015.02.002. PMC   4385192 . PMID   25772934.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  7. Vervoort VS, Viljoen D, Smart R, Suthers G, DuPont BR, Abbott A; et al. (2002). "Sorting nexin 3 (SNX3) is disrupted in a patient with a translocation t(6;13)(q21;q12) and microcephaly, microphthalmia, ectrodactyly, prognathism (MMEP) phenotype". J Med Genet. 39 (12): 893–9. doi:10.1136/jmg.39.12.893. PMC   1757218 . PMID   12471201.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  8. Casey J, Kawaguchi R, Morrissey M, Sun H, McGettigan P, Nielsen JE; et al. (2011). "First implication of STRA6 mutations in isolated anophthalmia, microphthalmia, and coloboma: a new dimension to the STRA6 phenotype". Hum Mutat. 32 (12): 1417–26. doi:10.1002/humu.21590. PMC   3918001 . PMID   21901792.{{cite journal}}: CS1 maint: multiple names: authors list (link)